BCYC

Bicycle Therapeutics Plc-adr

-$105.5M

Net Activity

Institutions Holding

98

Popularity Rank

#4488

Avg Weight

0.10%

Total Value

$175.3M

Ownership Trend

98 institutions currently hold BCYC, with 58 net buyers and 43 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

43

Net Buying Institutions

58

Key Holders

View all 98 holding institutions

Quarterly Activity

Recent Activity

+$78.4M

Total Buy Value

$80.6M

Total Sell Value

New buy15
Trim16
Add43
Sold out27

58

Net Buyers

43

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

1

Filings (90d)

$34K

Total Est. Value

8K shares

Planned Shares

Last Filed 2026-07-02
FilerFiling DateEst. Value
Lee Kevin2026-07-02$34K

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding BICYCLE THERAPEUTICS PLC-ADR (BCYC)?
Major stakeholders currently include Baker Bros. Advisors LP ($50.5M), Fcpm Iii Services B.v. ($16.1M), Armistice Capital, LLC ($15.8M). Based on the latest 13F filings, there are a total of 98 tracked investment funds and institutions maintaining positions in BCYC.
What is the overall institutional sentiment toward BCYC recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $105.5M, driven by 58 managers accumulating shares while 43 reduced their exposure.
Which institutions have been selling or reducing their BCYC positions?
In the latest period, 16 funds trimmed their holdings, and 27 managers completely exited their positions. The aggregate reported sell value was $80.6M.
Are there any notable investors adding BCYC to their portfolios?
Yes, buying activity remains notable. 15 institutions opened new positions in {ticker}, and 43 existing holders added to their shares. The total reported buy value for the quarter amounted to $78.4M.

Related Stocks